| Literature DB >> 35129304 |
Haihang Ye1, Chance Nowak2,3, Yaning Liu1, Yi Li2,4, Tingting Zhang1, Leonidas Bleris2,3,4, Zhenpeng Qin1,4,5,6.
Abstract
The ability to detect pathogens specifically and sensitively is critical to combat infectious diseases outbreaks and pandemics. Colorimetric assays involving loop-mediated isothermal amplification (LAMP) provide simple readouts yet suffer from the intrinsic non-template amplification. Herein, a highly specific and sensitive assay relying on plasmonic sensing of LAMP amplicons via DNA hybridization, termed as plasmonic LAMP, is developed for the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) RNA detection. This work has two important advances. First, gold and silver (Au-Ag) alloy nanoshells are developed as plasmonic sensors that have 4-times stronger extinction in the visible wavelengths and give a 20-times lower detection limit for oligonucleotides over Au counterparts. Second, the integrated method allows cutting the complex LAMP amplicons into short repeats that are amendable for hybridization with oligonucleotide-functionalized Au-Ag nanoshells. In the SARS-CoV-2 RNA detection, plasmonic LAMP takes ≈75 min assay time, achieves a detection limit of 10 copies per reaction, and eliminates the contamination from non-template amplification. It also shows better detection specificity and sensitivity over commercially available LAMP kits due to the additional sequence identification. This work opens a new route for LAMP amplicon detection and provides a method for virus testing at its early representation.Entities:
Keywords: SARS-CoV-2; hollow nanostructures; homogeneous assays; loop-mediated isothermal amplification; plasmonics
Mesh:
Substances:
Year: 2022 PMID: 35129304 PMCID: PMC9052780 DOI: 10.1002/smll.202107832
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 15.153
Scheme 1Schematic illustration of the major steps involved in the plasmonic LAMP for viral RNA detection. The RNA is first reverse transcribed and amplified into LAMP amplicons that are subjected to restriction enzymes digestion, forming short repeats that can be denatured into oligonucleotides for subsequent DNA hybridization linked with plasmonic sensors. RT‐LAMP is reverse transcription loop‐mediated isothermal amplification.
Figure 1Synthesis and characterization of Au–Ag nanoshells. A) Schematic illustration of the Au–Ag shells growth based on galvanic replacement reaction in the presence of 2 mm sodium citrate. TEM images of aliquots taken from the reaction when B) 1.0, C) 2.5, and D) 10.0 mL HAuCl4 was injected. Insets show the magnified TEM images (B,C) and HAADF‐STEM image (D) of individual particles. Scale bars in insets are 10 nm. E) EDX mapping image of an individual particle shown in (D).
Figure 2The LSPR properties of Au–Ag nanoshells and nanocages. LSPR extinction spectra of aliquots taken from the A) shell‐growth and B) cage‐growth reaction at an injection increment of 1 mL HAuCl4 (0.004% w/v). Insets show the models of shell and cage. Comparison of C) LSRP extinction peak λmax and D) maximal extinction intensity change during the growth of shells and cages. E) Simulation results of the extinction cross section area of a hollow shell with varied thickness (t). Inset shows the model. F) Normalized LSPR extinction of Au–Ag shells and 50 nm AuNPs at same particle concentration. Insets show the photographs of corresponding suspensions.
Figure 3Oligonucleotide detection by the Au–Ag‐shells‐based plasmonic coupling assay. A) Schematic illustration of the major steps involved in the plasmonic coupling assay. The operation can be simplified in one step (mixing probes and analyte in the buffer). B) Representative photographs of the completed assay solutions for the detection of target standards with varied concentrations. C) Normalized LSPR extinction spectra of detection results taken from (B). D) Corresponding calibration curve generated by plotting the extinction intensity (I ext) ratio against target concentration. E) A linear range of the calibration curve shown in (D). Error bars indicate the standard deviations (n = 6).
Figure 4Plasmonic LAMP for sensitive detection of SARS‐CoV‐2 RNA. A) Schematic illustration of the SARS‐CoV‐2 genome architecture and reaction proceeding. Target region, primers, cutting sites, and probe sequences are highlighted. B) Gel images showing the representative products after RT‐LAMP and enzyme digestion at different RNA input. C) Photographs taken from the completed assay at varied RNA input (copies µL−1). The red box highlights the visual detection limit. D) Corresponding LSPR extinction spectra (normalized at 537 nm) of the detection results shown in (C). E) Linear region of the calibration curve shown in (D). Error bars indicate the standard deviations of six parallel measurements. RSV is respiratory syncytial virus, and its RNA was extracted and cleaned before use.
Figure 5Comparison of plasmonic LAMP and a commercially available colorimetric LAMP kit for SARS‐CoV‐2 RNA detection. A) Photograph of colorimetric LAMP reaction with different RNA inputs and incubation time at 65 °C. Red box highlights the visually detectable sample. RSV RNA (50 copies µL−1) was used as a negative control. B) Detection results of plasmonic LAMP with different LAMP incubation times. At indicated times, LAMP products were processed for plasmonic sensing using Au–Ag‐shells‐based probes. Dashed line marks the background (3 times standard deviation above mean of zero indicator). Blue and green arrows indicate the detection limits for 15 and 45 min, respectively. C) Gel image of positive and negative controls obtained by colorimetric LAMP (blue) and plasmonic LAMP (red). The symbols (−) and (+) indicate 0 and 50 SARS‐CoV‐2 RNA copies µL−1 inputs, respectively. Both reactions were conducted at 65 °C for 45 min.
Analytical performance of plasmonic LAMP detection of SARS‐CoV‐2 RNA‐spiked nasopharyngeal swab samples
| Viral copies in sample [copies µL−1] | Plasmonic LAMP |
|---|---|
| 50 | 6/6 |
| 25 | 6/6 |
| 5 | 6/6 |
| 2.5 | 4/6 |
| 0.5 | 1/6 |
| 0 | 0/6 |
Total positive samples versus total testing sample.